Telesis Bio Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2024 to a ratio of 4.43, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Telesis Bio Inc in Sep 30 2024 quarter, has decreased to 82 days, compared to 88 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 391 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 2721 to 2743.

What is Receivable Turnover Ratio?
What is Telesis Bio Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TBIO Receivables Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Receivable Change	-76.45 %	-83.81 %	-48.64 %	-7.54 %	-
Y / Y Revenue Change	-68.66 %	-84.39 %	-55.62 %	-26.32 %	-93.12 %
Receivable Turnover Ratio (TTM)	4.43	4.14	4.02	4.05	4.38
TBIO's Total Ranking	# 2743	# 2721	# 2716	# 2718	# 2671
Accounts Receivable average collection period days	82	88	91	90	83
Seq. Receivable Change	-5.4 %	-55.49 %	-44.6 %	0.97 %	-34.98 %
Seq. Revenue Change	30.39 %	-50.9 %	-64.94 %	39.62 %	-35.04 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 20
Healthcare Sector	# 392
Overall Market	# 2743

Receivable Turnover Ratio Statistics
High	Average	Low
150.82	30.02	3.25
(Jun 30 2020)		(Sep 30 2018)

TBIO Company Profile • Back to TBIO Efficiency Comparisons • Compare TBIO Receivables Turnover Ratio to its Competitors

Financial Statements
Telesis Bio Inc 's Accounts Receivable	$ 1 Millions	Visit TBIO's Balance sheet
Telesis Bio Inc 's Sales TTM	$ 12 Millions	Visit TBIO's Income Statement
Sources of TBIO's Revenues		Visit TBIO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TBIO's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TBIO's Growth Rates	TBIO's Roa	TBIO's Inventory Turnover Ratio	TBIO's Dividend Comparisons
TBIO's Profitability Ratios	TBIO's Roi	TBIO's Asset Turnover Ratio	TBIO's Dividend Growth
TBIO's Valuation Ratios	TBIO's Roe	TBIO's Financial Strength Ratios	TBIO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
Fortrea Holdings Inc	26.41	$ 2,774.800 Millions	$ 105.050 Millions
Dih Holding Us Inc	25.89	$ 116.794 Millions	$ 4.511 Millions
Anika Therapeutics Inc	24.69	$ 162.681 Millions	$ 6.590 Millions
Lineage Cell Therapeutics Inc	23.85	$ 8.719 Millions	$ 0.366 Millions
Agenus Inc	23.56	$ 160.428 Millions	$ 6.810 Millions
Kymera Therapeutics Inc	23.35	$ 87.563 Millions	$ 3.750 Millions
Editas Medicine Inc	22.87	$ 61.758 Millions	$ 2.701 Millions
U S Physical Therapy Inc	22.39	$ 645.699 Millions	$ 28.841 Millions
Bespoke Extracts Inc	22.31	$ 1.080 Millions	$ 0.048 Millions
Cytomx Therapeutics Inc	22.28	$ 126.617 Millions	$ 5.684 Millions
One World Products Inc	22.21	$ 0.003 Millions	$ 0.000 Millions
Igc Pharma Inc	21.71	$ 1.183 Millions	$ 0.054 Millions
Innovative Eyewear Inc	21.65	$ 1.562 Millions	$ 0.072 Millions
Ethema Health Corporation	21.31	$ 5.675 Millions	$ 0.266 Millions
Generation Bio Co	20.94	$ 18.582 Millions	$ 0.887 Millions
Innovage Holding Corp	20.21	$ 786.512 Millions	$ 38.911 Millions
Co diagnostics Inc	19.94	$ 7.321 Millions	$ 0.367 Millions
Nutriband Inc	19.66	$ 2.022 Millions	$ 0.103 Millions
Innoviva Inc	19.25	$ 413.572 Millions	$ 21.480 Millions
Kiniksa Pharmaceuticals International Plc	18.60	$ 384.098 Millions	$ 20.650 Millions
Pulmatrix Inc	18.56	$ 10.005 Millions	$ 0.539 Millions
Milestone Scientific Inc	18.54	$ 8.862 Millions	$ 0.478 Millions
Hookipa Pharma inc	17.97	$ 49.999 Millions	$ 2.782 Millions
Macrogenics Inc	17.38	$ 141.329 Millions	$ 8.132 Millions
Zomedica Corp	17.34	$ 25.965 Millions	$ 1.497 Millions
Talkspace Inc	16.98	$ 179.853 Millions	$ 10.591 Millions
Medinotec Inc	16.59	$ 7.309 Millions	$ 0.441 Millions
Scorpius Holdings inc	16.51	$ 10.044 Millions	$ 0.608 Millions
Sangamo Therapeutics Inc	16.48	$ 52.291 Millions	$ 3.173 Millions
Stablecoin Development Corporation	16.33	$ 11.199 Millions	$ 0.686 Millions

Date modified: 2026-09-08T15:22:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.